Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | ADK | P55263 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19106545 | 0.92 | ADK (0.33) | KDM4EALDH1A1ADKLMNAGLA | |
| SCHEMBL19106535 | 0.90 | KDM4E (0.41) | KDM4EALDH1A1ADKLMNAGLA | |
| SCHEMBL17297356 | 0.89 | KDM4E (0.45) | KDM4EALDH1A1ADKLMNAGLA | |
| SCHEMBL19106534 | 0.89 | KDM4E (0.45) | KDM4EALDH1A1ADKLMNAGLA | |
| SCHEMBL19106541 | 0.89 | ADK (0.35) | KDM4EALDH1A1ADKLMNAGLA | |
| SCHEMBL17297482 | 0.88 | ESR1 (0.36) | KDM4EALDH1A1ADKLMNAGLA | |
| SCHEMBL19106538 | 0.88 | KDM4E (0.41) | KDM4EALDH1A1ADKLMNAGLA | |
| SCHEMBL26819681 | 0.88 | LIMK1 (0.35) | KDM4EALDH1A1LMNAGLAHPGD | |
| SCHEMBL19106536 | 0.87 | ALDH1A1 (0.37) | KDM4EALDH1A1ADKLMNAGLA | |
| SCHEMBL17297357 | 0.86 | KDM4E (0.47) | KDM4EALDH1A1ADKLMNAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10734588-B2 | Compound for organic electronic element, and organic electronic element and electronic device using same | DUK SAN NEOLUX CO., LTD (KR) | 2020-08-04 | — | — | US | disclosed |
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | NFE2L2, ESR1, VDAC2 | KDM4E 281/4885ALDH1A1 1024/4885ADK 4110/4885 |
| US-10734588-B2 | Compound for organic electronic element, and organic electronic element and electronic device using same | NFE2L2, ESR1, VDAC2 | KDM4E 281/4885ALDH1A1 1024/4885ADK 4110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.